Potential of Pegylated Interferon Alpha-2a in Behcet Uveitis: A Report of Five Cases

被引：16
|
作者：
Bielefeld, Philip [1 ]
Devilliers, Herve [1 ]
Deschasse, Clemence [2 ]
Saadoun, David [3 ]
Seve, Pascal [4 ]
Muselier, Aurore [1 ]
Creuzot-Garcher, Catherine [2 ]
Besancenot, Jean-Francois [1 ]
Bron, Alain Marie [2 ]
机构：
[1] Univ Hosp, Dept Internal Med & Syst Dis, 2 Blvd Marechal de Lattre de Tassigny,BP77908, F-21079 Dijon, France
[2] Univ Hosp, Dept Ophthalmol, Dijon, France
[3] Grp Hosp Pitie Salpetriere, Dept Internal Med 1, Paris, France
[4] Hop Croix Rousse, Hosp Civils Lyon, Dept Internal Med, Lyon, France
来源：
OCULAR IMMUNOLOGY AND INFLAMMATION | 2016年 / 24卷 / 05期
关键词：
LONG-TERM EFFICACY; THERAPY; DISEASE; SAFETY;
D O I：
10.3109/09273948.2015.1010652
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：599 / 602
页数：4
相关论文
共 50 条
  • [21] Efficacy and safety of a novel pegylated interferon alpha-2a in Egyptian patients with genotype 4 chronic hepatitis C
    Taha, Alaa Awad
    El-Ray, Ahmad
    El-Ghannam, Maged
    Mounir, Bahaa
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2010, 24 (10): : 597 - 602
  • [22] Pegylated interferon alpha-2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
    Gowina, K.
    Jain, T.
    Kosiorek, H.
    Tibes, R.
    Camoriano, J.
    Palmer, J.
    Mesa, R.
    LEUKEMIA RESEARCH, 2017, 54 : 73 - 77
  • [23] Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis
    Kamal, Sanaa M.
    Ahmed, Amany
    Mahmoud, Sara
    Nabegh, Leila
    El Gohary, Iman
    Obadan, Isi
    Hafez, Tamer
    Ghoraba, Dahlia
    Aziz, Ahmed A.
    Metaoei, Mona
    LIVER INTERNATIONAL, 2011, 31 (03) : 401 - 411
  • [24] Efficacy and Safety of Interferon Alpha 2A and Pegylated Interferon Alpha 2A in Inflammatory Macular Edema
    Couret, Chloe
    Servant, Marion
    Lebranchu, Pierre
    Hamidou, Mohamed
    Weber, Michel
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (02) : 329 - 336
  • [25] Effectiveness and safety of low-dose interferon alpha-2a treatment in Behcet's Syndrome with refractory vascular or neurological involvement: a case series
    Sun, Luxi
    Hou, Yunxia
    Zhang, Lifan
    Liu, JinJing
    Li, Lu
    Wang, Zhimian
    Yu, Xin
    Zhang, Menghao
    Liu, Xiaoqing
    Zhao, Yan
    Zheng, Wenjie
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [26] Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema
    De Simone, L.
    Sangiovanni, A.
    Aldigeri, R.
    Mastrofilippo, V.
    Bolletta, E.
    Invernizzi, A.
    Fares, L.
    Pipitone, N.
    Fontana, L.
    Salvarani, C.
    Cimino, L.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2020, 28 (02) : 322 - 328
  • [27] The Efficacy of a Hansenula-Derived 20 kDa Pegylated Interferon Alpha-2a in the Treatment of Genotype 4 Chronic Hepatitis C
    Shehab, Hany
    Elbaz, Tamer
    Deraz, Dalia
    Hafez, Amal
    Elattar, Inas
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (09): : 727 - 733
  • [28] Efficacy and safety of interferon α2a as an add-on treatment for refractory Behcet's uveitis
    Zheng, W. J.
    Shi, J.
    Zhao, C.
    Liu, J. J.
    Zhou, J. X.
    Gao, F.
    Zhang, M. F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (06) : S177 - S177
  • [29] Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behcet's Disease
    Park, Ji-Youn
    Chung, Yoo-Ri
    Lee, Kihwang
    Song, Ji Hun
    Lee, Eun-So
    YONSEI MEDICAL JOURNAL, 2015, 56 (04) : 1158 - 1162
  • [30] Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behcet's uveitis
    Shi, Jing
    Zhao, Chan
    Zhou, Jiaxin
    Liu, Jinjing
    Wang, Li
    Gao, Fei
    Zeng, Xiaofeng
    Zhang, Meifen
    Zheng, Wenjie
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10
12345